nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—SLC22A7—Docetaxel—ovarian cancer	0.0985	1	CbGbCtD
Cefotaxime—Vomiting—Altretamine—ovarian cancer	0.00714	0.00793	CcSEcCtD
Cefotaxime—Nausea—Altretamine—ovarian cancer	0.00667	0.0074	CcSEcCtD
Cefotaxime—Pain—Carboplatin—ovarian cancer	0.00664	0.00736	CcSEcCtD
Cefotaxime—Tenderness—Paclitaxel—ovarian cancer	0.00657	0.00729	CcSEcCtD
Cefotaxime—Neutropenia—Chlorambucil—ovarian cancer	0.00657	0.00728	CcSEcCtD
Cefotaxime—Dermatitis bullous—Vinorelbine—ovarian cancer	0.00647	0.00718	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Chlorambucil—ovarian cancer	0.00621	0.00689	CcSEcCtD
Cefotaxime—Body temperature increased—Carboplatin—ovarian cancer	0.00614	0.00681	CcSEcCtD
Cefotaxime—Jaundice—Chlorambucil—ovarian cancer	0.0061	0.00677	CcSEcCtD
Cefotaxime—Bronchospasm—Melphalan—ovarian cancer	0.00602	0.00668	CcSEcCtD
Cefotaxime—Local reaction—Epirubicin—ovarian cancer	0.00592	0.00657	CcSEcCtD
Cefotaxime—Neutropenia—Topotecan—ovarian cancer	0.00585	0.00648	CcSEcCtD
Cefotaxime—Neutropenia—Melphalan—ovarian cancer	0.00572	0.00635	CcSEcCtD
Cefotaxime—Colitis—Paclitaxel—ovarian cancer	0.0055	0.00611	CcSEcCtD
Cefotaxime—Local reaction—Doxorubicin—ovarian cancer	0.00548	0.00608	CcSEcCtD
Cefotaxime—Candida infection—Paclitaxel—ovarian cancer	0.00547	0.00607	CcSEcCtD
Cefotaxime—Jaundice—Melphalan—ovarian cancer	0.00532	0.0059	CcSEcCtD
Cefotaxime—Erythema multiforme—Chlorambucil—ovarian cancer	0.00531	0.0059	CcSEcCtD
Cefotaxime—Bronchospasm—Vinorelbine—ovarian cancer	0.00526	0.00584	CcSEcCtD
Cefotaxime—Haemoglobin—Topotecan—ovarian cancer	0.00503	0.00558	CcSEcCtD
Cefotaxime—Haemorrhage—Topotecan—ovarian cancer	0.005	0.00555	CcSEcCtD
Cefotaxime—Neutropenia—Vinorelbine—ovarian cancer	0.005	0.00555	CcSEcCtD
Cefotaxime—Haemoglobin—Melphalan—ovarian cancer	0.00492	0.00546	CcSEcCtD
Cefotaxime—Haemorrhage—Melphalan—ovarian cancer	0.0049	0.00544	CcSEcCtD
Cefotaxime—Hepatitis—Melphalan—ovarian cancer	0.0049	0.00544	CcSEcCtD
Cefotaxime—Colitis—Docetaxel—ovarian cancer	0.00467	0.00518	CcSEcCtD
Cefotaxime—Candida infection—Docetaxel—ovarian cancer	0.00464	0.00515	CcSEcCtD
Cefotaxime—Angioedema—Chlorambucil—ovarian cancer	0.00447	0.00496	CcSEcCtD
Cefotaxime—Agranulocytosis—Vinorelbine—ovarian cancer	0.00445	0.00494	CcSEcCtD
Cefotaxime—Leukopenia—Chlorambucil—ovarian cancer	0.00438	0.00486	CcSEcCtD
Cefotaxime—Arrhythmia—Melphalan—ovarian cancer	0.00438	0.00486	CcSEcCtD
Cefotaxime—Renal impairment—Paclitaxel—ovarian cancer	0.00437	0.00485	CcSEcCtD
Cefotaxime—Convulsion—Chlorambucil—ovarian cancer	0.00424	0.0047	CcSEcCtD
Cefotaxime—Ill-defined disorder—Topotecan—ovarian cancer	0.00404	0.00448	CcSEcCtD
Cefotaxime—Angioedema—Topotecan—ovarian cancer	0.00398	0.00442	CcSEcCtD
Cefotaxime—Malaise—Topotecan—ovarian cancer	0.00393	0.00436	CcSEcCtD
Cefotaxime—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00391	0.00434	CcSEcCtD
Cefotaxime—Leukopenia—Topotecan—ovarian cancer	0.0039	0.00433	CcSEcCtD
Cefotaxime—Liver injury—Epirubicin—ovarian cancer	0.0039	0.00432	CcSEcCtD
Cefotaxime—Arrhythmia—Vinorelbine—ovarian cancer	0.00382	0.00424	CcSEcCtD
Cefotaxime—Leukopenia—Melphalan—ovarian cancer	0.00382	0.00424	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Paclitaxel—ovarian cancer	0.00375	0.00416	CcSEcCtD
Cefotaxime—Renal impairment—Docetaxel—ovarian cancer	0.00371	0.00411	CcSEcCtD
Cefotaxime—Convulsion—Melphalan—ovarian cancer	0.0037	0.0041	CcSEcCtD
Cefotaxime—Dermatitis bullous—Docetaxel—ovarian cancer	0.00369	0.00409	CcSEcCtD
Cefotaxime—Discomfort—Topotecan—ovarian cancer	0.00366	0.00406	CcSEcCtD
Cefotaxime—Liver injury—Doxorubicin—ovarian cancer	0.0036	0.004	CcSEcCtD
Cefotaxime—Anaphylactic shock—Topotecan—ovarian cancer	0.00356	0.00394	CcSEcCtD
Cefotaxime—Anaphylactic shock—Melphalan—ovarian cancer	0.00348	0.00386	CcSEcCtD
Cefotaxime—Thrombocytopenia—Topotecan—ovarian cancer	0.00348	0.00386	CcSEcCtD
Cefotaxime—Ill-defined disorder—Vinorelbine—ovarian cancer	0.00346	0.00384	CcSEcCtD
Cefotaxime—Pain—Chlorambucil—ovarian cancer	0.00341	0.00379	CcSEcCtD
Cefotaxime—Thrombocytopenia—Melphalan—ovarian cancer	0.00341	0.00378	CcSEcCtD
Cefotaxime—Angioedema—Vinorelbine—ovarian cancer	0.0034	0.00378	CcSEcCtD
Cefotaxime—Neutropenia—Paclitaxel—ovarian cancer	0.00336	0.00373	CcSEcCtD
Cefotaxime—Malaise—Vinorelbine—ovarian cancer	0.00336	0.00373	CcSEcCtD
Cefotaxime—Leukopenia—Vinorelbine—ovarian cancer	0.00334	0.0037	CcSEcCtD
Cefotaxime—Feeling abnormal—Chlorambucil—ovarian cancer	0.00329	0.00365	CcSEcCtD
Cefotaxime—Vaginal inflammation—Epirubicin—ovarian cancer	0.00328	0.00364	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00327	0.00362	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.00318	0.00353	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Docetaxel—ovarian cancer	0.00318	0.00352	CcSEcCtD
Cefotaxime—Urticaria—Chlorambucil—ovarian cancer	0.00317	0.00352	CcSEcCtD
Cefotaxime—Abdominal pain—Chlorambucil—ovarian cancer	0.00316	0.0035	CcSEcCtD
Cefotaxime—Body temperature increased—Chlorambucil—ovarian cancer	0.00316	0.0035	CcSEcCtD
Cefotaxime—Renal failure—Paclitaxel—ovarian cancer	0.00315	0.0035	CcSEcCtD
Cefotaxime—Colitis—Epirubicin—ovarian cancer	0.00315	0.00349	CcSEcCtD
Cefotaxime—Discomfort—Vinorelbine—ovarian cancer	0.00313	0.00348	CcSEcCtD
Cefotaxime—Candida infection—Epirubicin—ovarian cancer	0.00313	0.00347	CcSEcCtD
Cefotaxime—Vaginal infection—Epirubicin—ovarian cancer	0.00309	0.00343	CcSEcCtD
Cefotaxime—Aplastic anaemia—Epirubicin—ovarian cancer	0.00308	0.00341	CcSEcCtD
Cefotaxime—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00304	0.00337	CcSEcCtD
Cefotaxime—Pain—Topotecan—ovarian cancer	0.00304	0.00337	CcSEcCtD
Cefotaxime—Vaginal inflammation—Doxorubicin—ovarian cancer	0.00303	0.00336	CcSEcCtD
Cefotaxime—Bronchospasm—Docetaxel—ovarian cancer	0.003	0.00333	CcSEcCtD
Cefotaxime—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00298	0.0033	CcSEcCtD
Cefotaxime—Pain—Melphalan—ovarian cancer	0.00298	0.0033	CcSEcCtD
Cefotaxime—Hypersensitivity—Chlorambucil—ovarian cancer	0.00294	0.00326	CcSEcCtD
Cefotaxime—Feeling abnormal—Topotecan—ovarian cancer	0.00293	0.00325	CcSEcCtD
Cefotaxime—Colitis—Doxorubicin—ovarian cancer	0.00291	0.00323	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Topotecan—ovarian cancer	0.00291	0.00322	CcSEcCtD
Cefotaxime—Candida infection—Doxorubicin—ovarian cancer	0.0029	0.00321	CcSEcCtD
Cefotaxime—Haemoglobin—Paclitaxel—ovarian cancer	0.00289	0.00321	CcSEcCtD
Cefotaxime—Haemorrhage—Paclitaxel—ovarian cancer	0.00288	0.00319	CcSEcCtD
Cefotaxime—Vaginal infection—Doxorubicin—ovarian cancer	0.00286	0.00318	CcSEcCtD
Cefotaxime—Neutropenia—Docetaxel—ovarian cancer	0.00285	0.00316	CcSEcCtD
Cefotaxime—Aplastic anaemia—Doxorubicin—ovarian cancer	0.00285	0.00316	CcSEcCtD
Cefotaxime—Pruritus—Chlorambucil—ovarian cancer	0.00283	0.00313	CcSEcCtD
Cefotaxime—Urticaria—Topotecan—ovarian cancer	0.00282	0.00313	CcSEcCtD
Cefotaxime—Body temperature increased—Topotecan—ovarian cancer	0.00281	0.00312	CcSEcCtD
Cefotaxime—Abdominal pain—Topotecan—ovarian cancer	0.00281	0.00312	CcSEcCtD
Cefotaxime—Urticaria—Melphalan—ovarian cancer	0.00277	0.00307	CcSEcCtD
Cefotaxime—Diarrhoea—Chlorambucil—ovarian cancer	0.00273	0.00303	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Epirubicin—ovarian cancer	0.00272	0.00302	CcSEcCtD
Cefotaxime—Erythema multiforme—Paclitaxel—ovarian cancer	0.00272	0.00302	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.0027	0.00299	CcSEcCtD
Cefotaxime—Renal failure—Docetaxel—ovarian cancer	0.00267	0.00296	CcSEcCtD
Cefotaxime—Jaundice—Docetaxel—ovarian cancer	0.00265	0.00294	CcSEcCtD
Cefotaxime—Hypersensitivity—Topotecan—ovarian cancer	0.00262	0.00291	CcSEcCtD
Cefotaxime—Pain—Vinorelbine—ovarian cancer	0.0026	0.00288	CcSEcCtD
Cefotaxime—Arrhythmia—Paclitaxel—ovarian cancer	0.00257	0.00285	CcSEcCtD
Cefotaxime—Hypersensitivity—Melphalan—ovarian cancer	0.00256	0.00284	CcSEcCtD
Cefotaxime—Vomiting—Chlorambucil—ovarian cancer	0.00254	0.00282	CcSEcCtD
Cefotaxime—Agranulocytosis—Docetaxel—ovarian cancer	0.00254	0.00281	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.00252	0.00279	CcSEcCtD
Cefotaxime—Pruritus—Topotecan—ovarian cancer	0.00252	0.00279	CcSEcCtD
Cefotaxime—Feeling abnormal—Vinorelbine—ovarian cancer	0.00251	0.00278	CcSEcCtD
Cefotaxime—Renal impairment—Epirubicin—ovarian cancer	0.0025	0.00277	CcSEcCtD
Cefotaxime—Dermatitis bullous—Epirubicin—ovarian cancer	0.00249	0.00276	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00249	0.00276	CcSEcCtD
Cefotaxime—Pruritus—Melphalan—ovarian cancer	0.00246	0.00273	CcSEcCtD
Cefotaxime—Haemoglobin—Docetaxel—ovarian cancer	0.00245	0.00272	CcSEcCtD
Cefotaxime—Haemorrhage—Docetaxel—ovarian cancer	0.00244	0.00271	CcSEcCtD
Cefotaxime—Hepatitis—Docetaxel—ovarian cancer	0.00244	0.00271	CcSEcCtD
Cefotaxime—Diarrhoea—Topotecan—ovarian cancer	0.00243	0.0027	CcSEcCtD
Cefotaxime—Urticaria—Vinorelbine—ovarian cancer	0.00242	0.00268	CcSEcCtD
Cefotaxime—Abdominal pain—Vinorelbine—ovarian cancer	0.0024	0.00267	CcSEcCtD
Cefotaxime—Body temperature increased—Vinorelbine—ovarian cancer	0.0024	0.00267	CcSEcCtD
Cefotaxime—Diarrhoea—Melphalan—ovarian cancer	0.00238	0.00264	CcSEcCtD
Cefotaxime—Nausea—Chlorambucil—ovarian cancer	0.00237	0.00263	CcSEcCtD
Cefotaxime—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00233	0.00258	CcSEcCtD
Cefotaxime—Renal impairment—Doxorubicin—ovarian cancer	0.00231	0.00257	CcSEcCtD
Cefotaxime—Erythema multiforme—Docetaxel—ovarian cancer	0.00231	0.00256	CcSEcCtD
Cefotaxime—Dermatitis bullous—Doxorubicin—ovarian cancer	0.0023	0.00256	CcSEcCtD
Cefotaxime—Angioedema—Paclitaxel—ovarian cancer	0.00229	0.00254	CcSEcCtD
Cefotaxime—Vomiting—Topotecan—ovarian cancer	0.00226	0.00251	CcSEcCtD
Cefotaxime—Malaise—Paclitaxel—ovarian cancer	0.00226	0.00251	CcSEcCtD
Cefotaxime—Leukopenia—Paclitaxel—ovarian cancer	0.00224	0.00249	CcSEcCtD
Cefotaxime—Rash—Topotecan—ovarian cancer	0.00224	0.00249	CcSEcCtD
Cefotaxime—Hypersensitivity—Vinorelbine—ovarian cancer	0.00224	0.00249	CcSEcCtD
Cefotaxime—Dermatitis—Topotecan—ovarian cancer	0.00224	0.00248	CcSEcCtD
Cefotaxime—Headache—Topotecan—ovarian cancer	0.00223	0.00247	CcSEcCtD
Cefotaxime—Vomiting—Melphalan—ovarian cancer	0.00221	0.00246	CcSEcCtD
Cefotaxime—Rash—Melphalan—ovarian cancer	0.00219	0.00243	CcSEcCtD
Cefotaxime—Dermatitis—Melphalan—ovarian cancer	0.00219	0.00243	CcSEcCtD
Cefotaxime—Arrhythmia—Docetaxel—ovarian cancer	0.00218	0.00242	CcSEcCtD
Cefotaxime—Convulsion—Paclitaxel—ovarian cancer	0.00217	0.00241	CcSEcCtD
Cefotaxime—Pruritus—Vinorelbine—ovarian cancer	0.00215	0.00239	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00214	0.00238	CcSEcCtD
Cefotaxime—Nausea—Topotecan—ovarian cancer	0.00211	0.00234	CcSEcCtD
Cefotaxime—Discomfort—Paclitaxel—ovarian cancer	0.00211	0.00234	CcSEcCtD
Cefotaxime—Diarrhoea—Vinorelbine—ovarian cancer	0.00208	0.00231	CcSEcCtD
Cefotaxime—Nausea—Melphalan—ovarian cancer	0.00207	0.00229	CcSEcCtD
Cefotaxime—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00205	0.00227	CcSEcCtD
Cefotaxime—Eosinophilia—Epirubicin—ovarian cancer	0.00204	0.00226	CcSEcCtD
Cefotaxime—Shock—Paclitaxel—ovarian cancer	0.00201	0.00223	CcSEcCtD
Cefotaxime—Thrombocytopenia—Paclitaxel—ovarian cancer	0.002	0.00222	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00198	0.0022	CcSEcCtD
Cefotaxime—Vomiting—Vinorelbine—ovarian cancer	0.00193	0.00214	CcSEcCtD
Cefotaxime—Neutropenia—Epirubicin—ovarian cancer	0.00192	0.00213	CcSEcCtD
Cefotaxime—Rash—Vinorelbine—ovarian cancer	0.00192	0.00213	CcSEcCtD
Cefotaxime—Dermatitis—Vinorelbine—ovarian cancer	0.00192	0.00213	CcSEcCtD
Cefotaxime—Headache—Vinorelbine—ovarian cancer	0.00191	0.00211	CcSEcCtD
Cefotaxime—Leukopenia—Docetaxel—ovarian cancer	0.0019	0.00211	CcSEcCtD
Cefotaxime—Eosinophilia—Doxorubicin—ovarian cancer	0.00188	0.00209	CcSEcCtD
Cefotaxime—Convulsion—Docetaxel—ovarian cancer	0.00184	0.00204	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00182	0.00202	CcSEcCtD
Cefotaxime—Nausea—Vinorelbine—ovarian cancer	0.00181	0.002	CcSEcCtD
Cefotaxime—Renal failure—Epirubicin—ovarian cancer	0.0018	0.002	CcSEcCtD
Cefotaxime—Jaundice—Epirubicin—ovarian cancer	0.00179	0.00198	CcSEcCtD
Cefotaxime—Neutropenia—Doxorubicin—ovarian cancer	0.00178	0.00197	CcSEcCtD
Cefotaxime—Pain—Paclitaxel—ovarian cancer	0.00175	0.00194	CcSEcCtD
Cefotaxime—Anaphylactic shock—Docetaxel—ovarian cancer	0.00173	0.00192	CcSEcCtD
Cefotaxime—Agranulocytosis—Epirubicin—ovarian cancer	0.00171	0.0019	CcSEcCtD
Cefotaxime—Shock—Docetaxel—ovarian cancer	0.00171	0.00189	CcSEcCtD
Cefotaxime—Thrombocytopenia—Docetaxel—ovarian cancer	0.0017	0.00188	CcSEcCtD
Cefotaxime—Feeling abnormal—Paclitaxel—ovarian cancer	0.00169	0.00187	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00168	0.00187	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00167	0.00186	CcSEcCtD
Cefotaxime—Renal failure—Doxorubicin—ovarian cancer	0.00167	0.00185	CcSEcCtD
Cefotaxime—Haemoglobin—Epirubicin—ovarian cancer	0.00165	0.00184	CcSEcCtD
Cefotaxime—Jaundice—Doxorubicin—ovarian cancer	0.00165	0.00183	CcSEcCtD
Cefotaxime—Haemorrhage—Epirubicin—ovarian cancer	0.00165	0.00183	CcSEcCtD
Cefotaxime—Hepatitis—Epirubicin—ovarian cancer	0.00165	0.00183	CcSEcCtD
Cefotaxime—Urticaria—Paclitaxel—ovarian cancer	0.00163	0.0018	CcSEcCtD
Cefotaxime—Abdominal pain—Paclitaxel—ovarian cancer	0.00162	0.00179	CcSEcCtD
Cefotaxime—Body temperature increased—Paclitaxel—ovarian cancer	0.00162	0.00179	CcSEcCtD
Cefotaxime—Agranulocytosis—Doxorubicin—ovarian cancer	0.00158	0.00176	CcSEcCtD
Cefotaxime—Erythema multiforme—Epirubicin—ovarian cancer	0.00156	0.00173	CcSEcCtD
Cefotaxime—Haemoglobin—Doxorubicin—ovarian cancer	0.00153	0.0017	CcSEcCtD
Cefotaxime—Hepatitis—Doxorubicin—ovarian cancer	0.00152	0.00169	CcSEcCtD
Cefotaxime—Haemorrhage—Doxorubicin—ovarian cancer	0.00152	0.00169	CcSEcCtD
Cefotaxime—Hypersensitivity—Paclitaxel—ovarian cancer	0.00151	0.00167	CcSEcCtD
Cefotaxime—Pain—Docetaxel—ovarian cancer	0.00148	0.00164	CcSEcCtD
Cefotaxime—Arrhythmia—Epirubicin—ovarian cancer	0.00147	0.00163	CcSEcCtD
Cefotaxime—Pruritus—Paclitaxel—ovarian cancer	0.00145	0.00161	CcSEcCtD
Cefotaxime—Erythema multiforme—Doxorubicin—ovarian cancer	0.00144	0.0016	CcSEcCtD
Cefotaxime—Feeling abnormal—Docetaxel—ovarian cancer	0.00143	0.00158	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00142	0.00157	CcSEcCtD
Cefotaxime—Diarrhoea—Paclitaxel—ovarian cancer	0.0014	0.00155	CcSEcCtD
Cefotaxime—Abdominal pain—Docetaxel—ovarian cancer	0.00137	0.00152	CcSEcCtD
Cefotaxime—Body temperature increased—Docetaxel—ovarian cancer	0.00137	0.00152	CcSEcCtD
Cefotaxime—Arrhythmia—Doxorubicin—ovarian cancer	0.00136	0.00151	CcSEcCtD
Cefotaxime—Ill-defined disorder—Epirubicin—ovarian cancer	0.00133	0.00147	CcSEcCtD
Cefotaxime—Vomiting—Paclitaxel—ovarian cancer	0.0013	0.00144	CcSEcCtD
Cefotaxime—Malaise—Epirubicin—ovarian cancer	0.00129	0.00143	CcSEcCtD
Cefotaxime—Rash—Paclitaxel—ovarian cancer	0.00129	0.00143	CcSEcCtD
Cefotaxime—Dermatitis—Paclitaxel—ovarian cancer	0.00129	0.00143	CcSEcCtD
Cefotaxime—Leukopenia—Epirubicin—ovarian cancer	0.00128	0.00142	CcSEcCtD
Cefotaxime—Headache—Paclitaxel—ovarian cancer	0.00128	0.00142	CcSEcCtD
Cefotaxime—Hypersensitivity—Docetaxel—ovarian cancer	0.00128	0.00142	CcSEcCtD
Cefotaxime—Convulsion—Epirubicin—ovarian cancer	0.00124	0.00138	CcSEcCtD
Cefotaxime—Ill-defined disorder—Doxorubicin—ovarian cancer	0.00123	0.00136	CcSEcCtD
Cefotaxime—Pruritus—Docetaxel—ovarian cancer	0.00123	0.00136	CcSEcCtD
Cefotaxime—Nausea—Paclitaxel—ovarian cancer	0.00122	0.00135	CcSEcCtD
Cefotaxime—Discomfort—Epirubicin—ovarian cancer	0.00121	0.00134	CcSEcCtD
Cefotaxime—Malaise—Doxorubicin—ovarian cancer	0.0012	0.00133	CcSEcCtD
Cefotaxime—Leukopenia—Doxorubicin—ovarian cancer	0.00119	0.00132	CcSEcCtD
Cefotaxime—Diarrhoea—Docetaxel—ovarian cancer	0.00119	0.00132	CcSEcCtD
Cefotaxime—Anaphylactic shock—Epirubicin—ovarian cancer	0.00117	0.0013	CcSEcCtD
Cefotaxime—Shock—Epirubicin—ovarian cancer	0.00115	0.00128	CcSEcCtD
Cefotaxime—Convulsion—Doxorubicin—ovarian cancer	0.00115	0.00127	CcSEcCtD
Cefotaxime—Thrombocytopenia—Epirubicin—ovarian cancer	0.00115	0.00127	CcSEcCtD
Cefotaxime—Discomfort—Doxorubicin—ovarian cancer	0.00112	0.00124	CcSEcCtD
Cefotaxime—Vomiting—Docetaxel—ovarian cancer	0.0011	0.00122	CcSEcCtD
Cefotaxime—Rash—Docetaxel—ovarian cancer	0.00109	0.00121	CcSEcCtD
Cefotaxime—Dermatitis—Docetaxel—ovarian cancer	0.00109	0.00121	CcSEcCtD
Cefotaxime—Headache—Docetaxel—ovarian cancer	0.00109	0.0012	CcSEcCtD
Cefotaxime—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00108	0.0012	CcSEcCtD
Cefotaxime—Shock—Doxorubicin—ovarian cancer	0.00106	0.00118	CcSEcCtD
Cefotaxime—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00106	0.00118	CcSEcCtD
Cefotaxime—Nausea—Docetaxel—ovarian cancer	0.00103	0.00114	CcSEcCtD
Cefotaxime—Pain—Epirubicin—ovarian cancer	0.001	0.00111	CcSEcCtD
Cefotaxime—Feeling abnormal—Epirubicin—ovarian cancer	0.000964	0.00107	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000956	0.00106	CcSEcCtD
Cefotaxime—Urticaria—Epirubicin—ovarian cancer	0.000929	0.00103	CcSEcCtD
Cefotaxime—Pain—Doxorubicin—ovarian cancer	0.000925	0.00103	CcSEcCtD
Cefotaxime—Abdominal pain—Epirubicin—ovarian cancer	0.000924	0.00103	CcSEcCtD
Cefotaxime—Body temperature increased—Epirubicin—ovarian cancer	0.000924	0.00103	CcSEcCtD
Cefotaxime—Feeling abnormal—Doxorubicin—ovarian cancer	0.000892	0.000989	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000885	0.000982	CcSEcCtD
Cefotaxime—Hypersensitivity—Epirubicin—ovarian cancer	0.000862	0.000956	CcSEcCtD
Cefotaxime—Urticaria—Doxorubicin—ovarian cancer	0.00086	0.000954	CcSEcCtD
Cefotaxime—Abdominal pain—Doxorubicin—ovarian cancer	0.000855	0.000949	CcSEcCtD
Cefotaxime—Body temperature increased—Doxorubicin—ovarian cancer	0.000855	0.000949	CcSEcCtD
Cefotaxime—Pruritus—Epirubicin—ovarian cancer	0.000827	0.000918	CcSEcCtD
Cefotaxime—Diarrhoea—Epirubicin—ovarian cancer	0.0008	0.000888	CcSEcCtD
Cefotaxime—Hypersensitivity—Doxorubicin—ovarian cancer	0.000797	0.000884	CcSEcCtD
Cefotaxime—Pruritus—Doxorubicin—ovarian cancer	0.000766	0.000849	CcSEcCtD
Cefotaxime—Vomiting—Epirubicin—ovarian cancer	0.000744	0.000825	CcSEcCtD
Cefotaxime—Diarrhoea—Doxorubicin—ovarian cancer	0.00074	0.000821	CcSEcCtD
Cefotaxime—Rash—Epirubicin—ovarian cancer	0.000737	0.000818	CcSEcCtD
Cefotaxime—Dermatitis—Epirubicin—ovarian cancer	0.000737	0.000817	CcSEcCtD
Cefotaxime—Headache—Epirubicin—ovarian cancer	0.000733	0.000813	CcSEcCtD
Cefotaxime—Nausea—Epirubicin—ovarian cancer	0.000695	0.000771	CcSEcCtD
Cefotaxime—Vomiting—Doxorubicin—ovarian cancer	0.000688	0.000763	CcSEcCtD
Cefotaxime—Rash—Doxorubicin—ovarian cancer	0.000682	0.000757	CcSEcCtD
Cefotaxime—Dermatitis—Doxorubicin—ovarian cancer	0.000682	0.000756	CcSEcCtD
Cefotaxime—Headache—Doxorubicin—ovarian cancer	0.000678	0.000752	CcSEcCtD
Cefotaxime—Nausea—Doxorubicin—ovarian cancer	0.000643	0.000713	CcSEcCtD
